ng-nitroarginine methyl ester has been researched along with Opioid-Related Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amini-Khoei, H; Dehpour, A; Hassanipour, M; Imran-Khan, M; Rahimi, N; Rezayat, SM; Shafaroodi, H; Shirzadian, A | 1 |
| Ito, S; Matsubayashi, K; Mori, T; Sawaguchi, T | 1 |
| Kimes, AS; London, ED; Vaupel, DB | 1 |
| Balducci, C; Koob, GF; Pulvirenti, L | 1 |
1 review(s) available for ng-nitroarginine methyl ester and Opioid-Related Disorders
| Article | Year |
|---|---|
Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.
Topics: Adrenergic alpha-Agonists; Animals; Arginine; Blood Pressure; Clonidine; Depression, Chemical; Enzyme Inhibitors; Heart Rate; Indazoles; Morphine; Narcotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Opioid-Related Disorders; Ornithine; Substance Withdrawal Syndrome | 1995 |
3 other study(ies) available for ng-nitroarginine methyl ester and Opioid-Related Disorders
| Article | Year |
|---|---|
Atorvastatin attenuates the antinociceptive tolerance of morphine via nitric oxide dependent pathway in male mice.
Topics: Animals; Arginine; Atorvastatin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Morphine; Narcotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Opioid-Related Disorders; Pain Measurement; Pain Threshold; Signal Transduction | 2016 |
Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome.
Topics: alpha-Tocopherol; Animals; Ascorbic Acid; Enzyme Inhibitors; Free Radical Scavengers; Hydroxyl Radical; Male; Mice; Naloxone; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Opioid-Related Disorders; Phospholipase A2 Inhibitors; Substance Withdrawal Syndrome; Superoxides | 2007 |
Inhibition of nitric oxide synthesis reduces intravenous cocaine self-administration in the rat.
Topics: Animals; Cocaine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Opioid-Related Disorders; Rats; Rats, Wistar; Reward; Self Administration | 1996 |